概括
复合腺相关病毒 (rAAV) 载体的全身用药具有风险,包括免疫反应和器官损伤. 了解剂量依赖性毒性和特定物种的安全性概况对于基因治疗的发展至关重要.
科学领域:
- 基因治疗 基因治疗
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
背景情况:
- 再组合腺相关病毒 (rAAV) 载体是基因疗法的关键工具.
- 系统性rAAV给药存在风险,特别是在高剂量 (>1 × 10^14vg/kg) 的情况下.
- 毒性可能是急性 (免疫反应,肝毒性,TMA) 或延迟 (慢性肝损伤,免疫激活).
研究的目的:
- 审查最近关于系统性rAAV毒性的文献.
- 专注于剂量水平,补充激活,内皮损伤,TMA和肝毒性.
- 检查人类和非人类灵长类动物 (NHPs) 之间的双向翻译安全概况.
主要方法:
- 对系统性rAAV毒性研究的文献综述.
- 对剂量依赖的不良影响的分析.
- 人类和NHP中毒性概况的比较.
主要成果:
- 高剂量的系统性rAAV可以导致急性和延迟的毒性,包括免疫反应,肝毒性和血栓性微血管病变 (TMA).
- 补充激活和内皮损伤与TMA有关.
- 人类和NHP之间存在不同的毒性概况,需要仔细的临床前评估.
结论:
- 彻底的临床前测试对于减轻与系统性rAAV基因疗法相关的风险至关重要.
- 了解特定物种的安全性对于成功转化到人类临床试验至关重要.
- 对rAAV毒性机制的进一步研究可以提高治疗安全性.
相关概念视频
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...


